Press Releases Year None2019201820172016 Gamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares July 8, 2019 PDF Version View HTML Gamida Cell Announces Pricing of $35 Million Public Offering of Ordinary Shares June 26, 2019 PDF Version View HTML Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares June 24, 2019 PDF Version View HTML Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel June 19, 2019 PDF Version View HTML Gamida Cell Bolsters Management Team with Appointment of Tracey Lodie, Ph.D., as Chief Scientific Officer June 5, 2019 PDF Version View HTML Gamida Cell Announces Data for Omidubicel Presented at the International Society for Cellular and Gene Therapy 2019 Annual Meeting May 31, 2019 PDF Version View HTML Gamida Cell to Hold Annual Meeting of Stockholders May 29, 2019 PDF Version View HTML Gamida Cell to Participate in Two Upcoming Healthcare Conferences in New York City May 9, 2019 PDF Version View HTML Gamida Cell Reports First Quarter 2019 Financial Results and Provides Company Update May 7, 2019 PDF Version View HTML Gamida Cell Announces the Date of Its First Quarter 2019 Financial Results and Webcast April 30, 2019 PDF Version View HTML Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 21
